This inventor holds 12 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignees: Roche Diabetes Care, Inc., Roche Diagnostics Operations, Inc., Roche Diagnostics International Ag. Active years: 1987-2025.
Location History:
- Houston, TX (US) (1987)
- Indianapolis, IN (US) (1992 - 2022)
Company Filing History:
4 out of 664 
4 out of 1,696 
3 out of 199 
Years Active: 1987-2025
Title: The Innovative Contributions of Maury Zivitz
Introduction
Maury Zivitz is a notable inventor based in Indianapolis, IN, who has made significant contributions to the field of medical technology. With a total of 11 patents to his name, Zivitz has focused on developing solutions that enhance patient care, particularly in diabetes management.
Latest Patents
Among his latest patents is a device and method for insulin dosing. This innovation provides essential instructions to patients regarding their insulin dosing, ensuring better management of their condition. Another significant patent is a method for the detection and handling of hypoglycemia. This method involves using a computing device to detect hypoglycemia in patients, compute a recommended carbohydrate amount for ingestion, and perform hypoglycemia surveillance to assess the effectiveness of the recommended treatment.
Career Highlights
Zivitz has worked with prominent companies in the healthcare sector, including Roche Diagnostics Operations, Inc. and Roche Diabetes Care, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in diabetes care.
Collaborations
Throughout his career, Zivitz has collaborated with esteemed professionals in the field, including Lois Jovanovic and Paul J Galley. These collaborations have further enriched his work and expanded the impact of his inventions.
Conclusion
Maury Zivitz's contributions to medical technology, particularly in diabetes management, highlight his dedication to improving patient outcomes. His innovative patents and collaborations with industry leaders underscore his role as a significant figure in the field of healthcare innovation.